News Quantified

PODD – insulet corporation (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Assessing Insulet's Valuation After Omnipod Expansion and Recent Share Price Volatility [Yahoo! Finance]

Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at Cowen Inc.

Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience

Insulet: Excellent Business, Valuation Hurdle Remains [Seeking Alpha]

Artisan International Small-Mid Fund Q3 2025 Contrarianism Pays Off [Seeking Alpha]

2.0%

BEAT

7.3%

BEAT

20.9%

MISS

-1.9%

BEAT

Canaccord Genuity

Sanford C. Bernstein

Royal Bank Of Canada

Form 4 INSULET CORP For: Dec 05 Filed by: STONESIFER TIMOTHY C.

Form 144 INSULET CORP Filed by: Manea Dan

Form 144 INSULET CORP Filed by: Manea Dan

Form 10-Q INSULET CORP For: Sep 30

Form 8-K INSULET CORP For: Nov 06

Top News Gainers

8/5 Insulet Reports Second Quarter 2019 Revenue of $177 Million, an Increase of 43% Year-Over-Year 21.4%

11/5 Form 8-K INSULET CORP For: Nov 05 10.5%

9/3 Form 8-K INSULET CORP For: Sep 03 9.4%

5/6 Insulet Co. (NASDAQ: PODD) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $115.00 price target on the stock. 5.4%

2/26 Diabetes Stock Insulet Drops 8.5% on Earnings Miss and Softer-Than-Expected Outlook [The Motley Fool] 4.4%

4/6 Insulet to Announce First Quarter 2020 Financial Results on May 7, 2020 4.2%

1/6 Insulet to Announce Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020 3.7%

9/24 Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Svb Leerink Llc from $160.00 to $185.00. They now have an "outperform" rating on the stock. 3.5%

2/26 Insulet Co. (NASDAQ: PODD) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $205.00 price target on the stock, down previously from $213.00. 3.5%

2/27 Form 4 INSULET CORP For: Feb 26 Filed by: Benjamin Eric 3.4%

Top News Decliners

2/25 Q4/2019 12/31/2019 EPS 0.080 ZacksConsensus 0.090 ActVsEst (0.010) - Miss -8.5%

10/22 Insulet Co. (NASDAQ: PODD) is now covered by analysts at Stifel Nicolaus. They set a "hold" rating on the stock. -8.4%

7/31 Form 8-K INSULET CORP For: Jul 31 -5.7%

2/24 Form 4 INSULET CORP For: Feb 21 Filed by: Spears Michael P -5.1%

3/31 Insulet Co. (NASDAQ: PODD) was downgraded by analysts at Berenberg Bank from a "buy" rating to a "hold" rating. -5.0%

3/10 Form 4 INSULET CORP For: Mar 06 Filed by: Lemoine David A -4.7%

3/2 Insulet Provides Update on Pivotal Study of Omnipod Horizon™ -4.5%

3/2 Form 4 INSULET CORP For: Feb 27 Filed by: Spears Michael P -4.0%

9/4 Insulet prices upsized convertible debt offering [Seeking Alpha] -3.8%

4/6 Why Diabetes Stock Insulet Fell 13% in March [The Motley Fool] -3.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day